Clovibactin (TFA)
Clovibactin TFA is the TFA salt form of Clovibactin. Clovibactin TFA is an antibiotic for drug-resistant bacterial pathogens without detectable resistance. Clovibactin TFA inihibits cell wall synthesis by targeting pyrophosphate of peptidoglycan precursors[1].
Product Specifications
UNSPSC
12352209
Target
Antibiotic; Bacterial
Type
Peptides
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/clovibactin-tfa.html
Purity
97.10
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
Molecular Formula
C43H70N10O11.xC2HF3O2
Molecular Weight
903.08 (free base)
References & Citations
[1]Shukla R, et al., A new antibiotic from an uncultured bacterium binds to an immutable target. bioRxiv [Preprint]. 2023 May 15:2023.05.15.540765.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Guselkumab Biosimilar (Monoclonal, IgG1 (E239D, M241L) )
Lentiviral mouse Tsx shRNA (UAS) - Lentiviral mouse Tsx shRNA (UAS, RFP) plasmid
HS6ST1 (Heparan Sulfate 6-O-Sulfotransferase 1, DKFZp547H098, FLJ25392, HS6ST, MGC116899, MGC116901) (MaxLight 405) discontinued